Unknown

Dataset Information

0

Optimal acquisition scheme for flow-compensated intravoxel incoherent motion diffusion-weighted imaging in the abdomen: An accurate and precise clinically feasible protocol.


ABSTRACT:

Purpose

Flow-compensated (FC) diffusion-weighted MRI (DWI) for intravoxel-incoherent motion (IVIM) modeling allows for a more detailed description of tissue microvasculature than conventional IVIM. The long acquisition time of current FC-IVIM protocols, however, has prohibited clinical application. Therefore, we developed an optimized abdominal FC-IVIM acquisition with a clinically feasible scan time.

Methods

Precision and accuracy of the FC-IVIM parameters were assessed by fitting the FC-IVIM model to signal decay curves, simulated for different acquisition schemes. Diffusion-weighted acquisitions were added subsequently to the protocol, where we chose the combination of b-value, diffusion time and gradient profile (FC or bipolar) that resulted in the largest improvement to its accuracy and precision. The resulting two optimized FC-IVIM protocols with 25 and 50 acquisitions (FC-IVIMopt25 and FC-IVIMopt50 ), together with a complementary acquisition consisting of 50 diffusion-weighting (FC-IVIMcomp ), were acquired in repeated abdominal free-breathing FC-IVIM imaging of seven healthy volunteers. Intersession and intrasession within-subject coefficient of variation of the FC-IVIM parameters were compared for the liver, spleen, and kidneys.

Results

Simulations showed that the performance of FC-IVIM improved in tissue with larger perfusion fraction and signal-to-noise ratio. The scan time of the FC-IVIMopt25 and FC-IVIMopt50 protocols were 8 and 16 min. The best in vivo performance was seen in FC-IVIMopt50 . The intersession within-subject coefficients of variation of FC-IVIMopt50 were 11.6%, 16.3%, 65.5%, and 36.0% for FC-IVIM model parameters diffusivity, perfusion fraction, characteristic time and blood flow velocity, respectively.

Conclusions

We have optimized the FC-IVIM protocol, allowing for clinically feasible scan times (8-16 min).

SUBMITTER: Gurney-Champion OJ 

PROVIDER: S-EPMC6899942 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7206040 | biostudies-literature
| S-EPMC11320536 | biostudies-literature
| S-EPMC6001424 | biostudies-literature
| S-EPMC4248278 | biostudies-other
| S-EPMC5546503 | biostudies-other
| S-EPMC8947183 | biostudies-literature
| S-EPMC7937866 | biostudies-literature
| S-EPMC11320521 | biostudies-literature
| S-EPMC5784995 | biostudies-literature
| S-EPMC7453742 | biostudies-literature